These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19463807)

  • 1. Biological variation in fasting serum insulin-like growth factor binding protein-1 (IGFBP-1) among individuals with a varying glucose tolerance.
    Borai A; Livingstone C; Mehta S; Zarif H; Abdelaal F; Ferns G
    Clin Biochem; 2009 Aug; 42(12):1270-4. PubMed ID: 19463807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum insulin-like growth factor binding protein-1: an improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance.
    Borai A; Livingstone C; Zarif H; Ferns G
    Ann Clin Biochem; 2009 Mar; 46(Pt 2):109-13. PubMed ID: 19164337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference change values for insulin and insulin-like growth factor binding protein-1 (IGFBP-1) in individuals with varying degrees of glucose tolerance.
    Borai A; Livingstone C; Ferns G
    Scand J Clin Lab Invest; 2013; 73(4):274-8. PubMed ID: 23548151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
    Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population.
    Lü Q; Tong N; Liu Y; Li N; Tang X; Zhao J; Cao H; Li D; Gou L; Zhang Y; Wan J; Jiang L
    Diabetes Res Clin Pract; 2009 Jun; 84(3):319-24. PubMed ID: 19442860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus.
    Lewitt MS; Hall K; Bang P; Brismar K
    Metabolism; 2005 Mar; 54(3):275-80. PubMed ID: 15736102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lipid and hsCRP levels in prediabetes--impaired fasting glucose (IFG) and impaired glucose tolerance (IGT).
    Chakarova N; Tankova T; Atanassova I; Dakovska L
    Diabetes Res Clin Pract; 2009 Oct; 86(1):56-60. PubMed ID: 19674805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance.
    Maddux BA; Chan A; De Filippis EA; Mandarino LJ; Goldfine ID
    Diabetes Care; 2006 Jul; 29(7):1535-7. PubMed ID: 16801575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH; Kaushal K; Siddals KW; Rudenski AS; Anderson SG; Gibson JM
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.
    Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining normalization of glucose intolerance in middle-aged Swedish men and women: a 8-10-year follow-up.
    Alvarsson M; Hilding A; Ostenson CG
    Diabet Med; 2009 Apr; 26(4):345-53. PubMed ID: 19388963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of leukocyte count with varying degrees of glucose intolerance in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-26).
    Gokulakrishnan K; Deepa R; Sampathkumar R; Balasubramanyam M; Mohan V
    Metab Syndr Relat Disord; 2009 Jun; 7(3):205-10. PubMed ID: 19284318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The change in the circulating insulin-like growth factor binding protein 1 isoform pattern during the course of oral glucose tolerance test.
    Nedić O; Masnikosa R
    Metabolism; 2008 May; 57(5):658-61. PubMed ID: 18442629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.
    Succurro E; Marini MA; Grembiale A; Lugarà M; Andreozzi F; Sciacqua A; Hribal ML; Lauro R; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.